【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2285次   下载 1576 本文二维码信息
码上扫一扫!
p38MAPK对大鼠肾小球系膜细胞表达NF-κB和COX-2的调控
魏倩萍1,邓华聪1*,赵劼2
0
(1.重庆医科大学第一附属医院内分泌科,重庆 400016;2.重庆医科大学超声工程研究所,重庆400016)
摘要:
目的:探讨p38丝裂原活化蛋白激酶(p38 mitogen-activated protein kinase,p38MAPK)、核因子-κB (nuclear factor-κB,NF-κB ) 和环氧化酶-2 (cyclooxygenase-2,COX-2)之间的关系,从而研究p38MAPK和NF-κB、COX-2在糖尿病肾病中的作用机制。方法:分别以一定浓度的高葡萄糖(25 mmol/L)、高胰岛素(100 mmol/L)、过氧化氢(100 μmol/L)和糖基化终产物(100 mg/L)孵育大鼠肾小球系膜细胞系HBZY-1一定时间;先分别以一定浓度的p38MAPK特异抑制剂SB203580(10 μmol/L)预处理细胞系HBZY-1,再给予上述4种因素孵育细胞系HBZY-1,观察细胞系HBZY-1 p38MAPK、NF-κB和COX-2的表达。结果:高葡萄糖、高胰岛素、过氧化氢和糖基化终产物均可独立激活p38MAPK,使其磷酸化表达量增加,NF-κB、COX-2表达也明显增加,与对照组比较有显著性差异(P<0.01);SB203580预处理后,NF-κB、COX-2表达显著降低,与相应刺激组比较差异有统计学意义(P<0.01)。结论:p38MAPK可通过激活NF-κB、COX-2而诱导DM时肾脏的损害, p38MAPK和NF-κB、COX-2在糖尿病肾病的发生发展过程中可能起重要作用。
关键词:  p38丝裂原活化蛋白激酶类  NF-κB  环氧化酶2  糖尿病肾病  肾小球系膜细胞
DOI:10.3724/SP.J.1008.2008.00241
投稿时间:2007-08-09修订日期:2008-01-09
基金项目:国家自然科学基金(30570744).
Role of p38MAPK in regulating expression of NF-κB and COX-2 in rat mesangial cell
WEI Qian-ping1,DENG Hua-cong1*,ZHAO Jie2
(1.Department of Endocrinology, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, China;2.Institute of Ultrasonic Engineering, the First Affiliated Hospital, Chongqing Medical University, Chongqing 400016)
Abstract:
Objective:To investigate the relationship between p38 mitogen-activated protein kinase (p38MAPK), nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2), so as to study the roles of p38MAPK, NF-κB and COX-2 in diabetic nephropathy. Methods: Rat mesangial cell line HBZY-1 was incubated with certain concentrations of glucose(25 mmol/L), insulin(100 mmol/L), H2O2(100 mmol/L) and glycation endproducts (AGEs)(100 mg/L) with or without pretreatment with SB203580, a specific inhibitor of p38MAPK, then the expression of p38MAPK, NF-κB and COX-2 in the HBZY-1 cells was examined. Results: High glucose, high insulin, H2O2 and AGEs independently activated p38MAPK, increased p38MAPK phosphorylation, and significantly up-regulated the expression of NF-κB and COX-2 compared with the control group (P<0.01). Pretreatment with SB203580 significantly decreased expression of NF-κB and COX-2 compared with the corresponding stimulating group (P<0.01). Conclusion: p38MAPK may induce renal damage during diabetic nephropathy by activating NF-κB and COX-2, indicating that p38MAPK, NF-κB and COX-2 may play important roles in the development of diabetic nephropathy.
Key words:  p38 mitogen-activated protein kinases  nuclear factor-kappa B  cyclooxygenase-2  diabetic nephropathy  mesangial cells